Delivery Order SPE2DX22D0049-SPE2D826FA7CC
Award Date 4/27/26
Potential Completion Date 4/28/26
Potential Value $422K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain issued a $398,970 delivery order to AmerisourceBergen Drug Corp on April 20, 2026, for pharmaceutical distribution under the DLA Troop Support Medical indefinite delivery contract. Place of performance is Conshohocken, PA. The order carries a firm fixed price structure with an ultimate completion date of April 21, 2026. AmerisourceBergen operates as the execution entity for DLA pharmaceutical distribution under its parent company Cencora, Inc.
- The Defense Logistics Agency's Medical Supply Chain issued a $121,717.68 delivery order to AmerisourceBergen Drug Corp on April 27, 2026, for pharmaceutical distribution to military healthcare facilities, with final completion by April 28, 2026. This is a firm fixed-price delivery order under the DLA Troop Support Medical indefinite delivery contract structure. Place of performance is Conshohocken, PA. AmerisourceBergen Drug Corp operates as the execution entity for DLA pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain issued a $31,343.79 delivery order to AmerisourceBergen Drug Corp on April 20, 2026, for pharmaceutical distribution under a DLA Troop Support Medical indefinite delivery contract. Place of performance is Conshohocken, PA. The order carries a firm fixed-price structure and an ultimate completion date of April 21, 2026. AmerisourceBergen Drug Corp operates as the execution entity for DLA pharmaceutical distribution within its parent company,...
- The Defense Logistics Agency Medical Supply Chain issued a $534,338.14 delivery order to AmerisourceBergen Drug Corp on April 1, 2026, for pharmaceutical distribution under the DLA Troop Support Medical Indefinite Delivery Contract. Place of performance is Conshohocken, PA. The order carries a firm fixed price and is due for ultimate completion on April 2, 2026. AmerisourceBergen Drug Corp operates as a division of parent company Cencora, Inc. and holds a $999,999,999.00 indefinite delivery...
- The Defense Logistics Agency's Medical Supply Chain issued a $18,926.09 delivery order to AmerisourceBergen Drug Corp on April 20, 2026, under the DLA Troop Support Medical indefinite delivery contract for pharmaceutical distribution. Place of performance is Conshohocken, PA. The order carries a firm fixed-price structure with an ultimate completion date of April 21, 2026. This represents a transactional pharmaceutical delivery order within AmerisourceBergen's portfolio of standing delivery...
- The Defense Logistics Agency's Medical Supply Chain issued a $285,762.81 delivery order to AmerisourceBergen Drug Corp on April 16, 2026, for pharmaceutical distribution under the DLA Troop Support Medical indefinite delivery contract. Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of April 17, 2026. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor supplying brand-name and generic...
- The Defense Logistics Agency's Medical Supply Chain issued a $1.794 million delivery order to AmerisourceBergen Drug Corp on April 22, 2026, for pharmaceutical distribution under the DLA Troop Support Medical indefinite delivery contract. Place of performance is Conshohocken, PA. The order carries a firm fixed-price structure with an ultimate completion date of April 23, 2026. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., and operates as the execution entity for DLA...
- The Defense Logistics Agency, Medical Supply Chain, issued a $39,138.02 delivery order to AmerisourceBergen Drug Corp on April 27, 2026, for pharmaceutical supply to military healthcare facilities. Place of performance is Conshohocken, PA. The order is firm fixed-price with an ultimate completion date of April 28, 2026. This delivery order was issued under a Defense Logistics Agency Troop Support Medical indefinite delivery contract, which serves as the standing vehicle for pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain issued a $32,526.69 delivery order to Amerisourcebergen Drug Corp on April 20, 2026, for pharmaceutical distribution under the DLA Troop Support Medical indefinite delivery contract. Place of performance is Conshohocken, PA. The order has a firm fixed-price structure with an ultimate completion date of April 21, 2026. This represents a transactional pharmaceutical delivery against Amerisourcebergen's standing supply arrangement with DLA,...
- The Defense Logistics Agency's Medical Supply Chain issued a $2,573.57 delivery order to Amerisourcebergen Drug Corp on April 27, 2026, under the DLA Troop Support Medical indefinite delivery contract for pharmaceutical supply. Place of performance is Conshohocken, PA. The order has a firm fixed-price structure and an ultimate completion date of April 28, 2026. This represents a transactional pharmaceutical delivery typical of Amerisourcebergen's high-volume position on the DLA Troop Support...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D826FA7CCDelivery Order
The Defense Logistics Agency's Medical Supply Chain issued a $422,170.35 delivery order to AmerisourceBergen Drug Corp on April 27, 2026, for pharmaceutical distribution under a DLA Troop Support Medical indefinite delivery contract. Place of performance is Conshohocken, PA. The order is firm fixed-price with an ultimate completion date of April 28, 2026. AmerisourceBergen Drug Corp operates as the execution entity for DLA pharmaceutical distribution within Cencora, Inc., its parent company, and holds standing position on five top DLA Troop Support Medical SPE2DX-series indefinite delivery contracts supporting worldwide military healthcare supply across multiple therapeutic domains.
Generated 7/26/26, 9:42 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $422.2k | 4/26/26 |